Pear Therapeutics has developed reVIVETM, a prescription digital therapeutic to be used in combination with medication for treating GAD and PD
Patient-Facing Smartphone Application + Benzodiazepine Medication
reVIVETM produces a significant decrease in self-assessed measures of anxiety in patients diagnosed with GAD
Repetto et al. Pers and Ubiq Computing. 2011.
reVIVETM is not yet FDA-cleared or available in the United States